Nevirapine concentrations in newborns receiving an extended prophylactic regimen

Journal of Acquired Immune Deficiency Syndromes

Volumn 47, Issue 3, 2008, Pages 334-337

  Mirochnick, Mark ^a,j   Nielsen Saines, Karin ^b   Pilotto, Jose Henrique ^c   Pinto, Jorge ^d   Jiménez, Eleanor ^e   Veloso, Valdilea G ^f   Parsons, Teresa ^g   Watts, D Heather ^h   Moye, Jack ^h   Mofenson, Lynne M ^h   Camarca, Margaret ⁱ   Bryson, Yvonne ^b   Morgado, Mariza ^k   Yu, Eunice ⁱ   Bethel, James ^l   Hawkins, Elizabeth ^m   Smith, Elizabeth ⁿ   Zwerski, Sheryl ^l   McDonough, Marita D ^o   Lancaster, Charles T ^p   PharoRuth, Cristina ^q   Dickover, Ruth E ^b   more..

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Hospital Geral de Nova Iguacu   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e San Juan City Hospital   (Puerto Rico)

^f Funda??o Oswaldo Cruz   (Brazil)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

ⁱ WESTAT   (United States)

^j BOSTON MEDICAL CENTER   (United States)

^k INSTITUTO OSWALDO CRUZ   (Brazil)

^l Westat ^*

^m SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

ⁿ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^o BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^p GLAXOSMITHKLINE   (United States)

^q GLAXOSMITHKLINE   (United Kingdom)

more..

Author keywords

Mother to child HIV transmission; Neonate; Nevirapine; Pharmacokinetics

Indexed keywords

LAMIVUDINE; NELFINAVIR; NEVIRAPINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOTHERAPY; NEWBORN; NEWBORN CARE; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE TRANSMISSION; DRUG EFFECT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS 1; MULTICENTER STUDY; PREGNANCY COMPLICATION; TREATMENT OUTCOME; VIROLOGY; VIRUS LOAD;

ANTI-HIV AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE TRANSMISSION, VERTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 42449090754     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)